Pillstats
Rx only · Tablet, Extended Release · Oral

Naltrexone Hydrochloride And Bupropion Hydrochloride

Brands: Contrave Extended-Release · Bupropion Hydrochloride + Naltrexone Hydrochloride

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US1 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCN06AX12
RxCUI (US)42347
US makers1 labelers
Packages2
DEA / ScheduleNone

Medicaid dispensing volume

No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Nalpropion Pharmaceuticals LLCunknown2SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Oct 5, 2018
    RECALLRecall (Class III): Contrave (naltrexone HCl and bupropion HCl). Extended-Release Tablets, 8mg/90 mg, 120-count bottles, Rx only, Distribut…

    Container packaging defect. — Recalling firm: Orexigen Therapeutics, Inc. — Within the United States

  • Aug 9, 2018
    RECALLRecall (Class III): Contrave (naltrexone HCl and bupropion HCl) Extended-Release Tablets, 8 mg/90 mg, 120-count bottle, Rx only, Distribute…

    Defective Container: Customer complaints of punctures in the bottle. — Recalling firm: Orexigen Therapeutics, Inc. — Nationwide in the USA